Article by ImPrEP and Instituto Nacional de Infectologia Evandro Chagas/Fiocruz/Brasil published at BMC Infectious Diseases in December 2019 https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-4704-x
ImPrEP article published in JMIR , in 2019, Jun, Publicationshttps://publichealth.jmir.org/2019/2/e13771/
In Brazil, as well as in other parts of the world, relationship applications have been the main platform for sexual…
The results of the first six months of implementation of the prophylaxis were presented during the World Conference on Aids…
PrEP is not intended to be the only way of prevention to HIV, but one among other available options. The…
The developing countries have specific characteristics that, in general, do not appear in studies with PrEP carried out in the…
Last month, PrEP Brazil’s team published an article on the magazine The Lancet HIV. The results of one year of PrEP…
Publicações: Protocolo Clínico e Diretrizes Terapêuticas, Assistência e Tratamento, PrEP (Assistência e Tratamento), Políticas de saúde, Medicamentos, Profissionais de Saúde HIV/Aids Última modificação: 21.12.2017 - 14:40…
Truvada® is an antiretroviral drug approved by the Food and Drugs Administration (FDA), a body similar to the National Agency…
Men who have sex with men (MSM), transvestites and transsexual women; Be 18 years of age or older; Not being…
